Evidence map›Paper›PMID 34378772›Full record

ArticleDisease models & mechanisms2021

Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model.

Benjamin Chatel, Sylvie Ducreux, Zeina Harhous, Nadia Bendridi, Isabelle Varlet, Augustin C Ogier, Monique Bernard, Julien Gondin, Jennifer Rieusset, Håkan Westerblad and 2 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Benjamin ChatelAix-Marseille Université, CRMBM UMR CNRS 7339, 13385 Marseille, France.ORCID 0000-0002-8197-1903
Sylvie DucreuxCarMeN Laboratory, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon1, F-69310 Pierre-Bénite et F-69500 Bron, France.ORCID 0000-0003-3207-9537
Zeina HarhousCarMeN Laboratory, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon1, F-69310 Pierre-Bénite et F-69500 Bron, France.ORCID 0000-0001-7611-5160
Nadia BendridiCarMeN Laboratory, INSERM, INRA, INSA Lyon, Université Claude Bernard Lyon 1, 69600 Oullins, France.ORCID 0000-0003-0456-7007
Isabelle VarletAix-Marseille Université, CRMBM UMR CNRS 7339, 13385 Marseille, France.ORCID 0000-0002-1711-7980
Augustin C OgierAix-Marseille Université, Université de Toulon, CNRS, LIS, 13397 Marseille, France.ORCID 0000-0001-9178-9964
Monique BernardAix-Marseille Université, CRMBM UMR CNRS 7339, 13385 Marseille, France.ORCID 0000-0002-3179-8698
Julien GondinInstitut NeuroMyoGène, UMR CNRS 5310 - INSERM U1217, Université Claude Bernard Lyon 1, F-69008 Lyon, France.ORCID 0000-0002-3108-605X
Jennifer RieussetCarMeN Laboratory, UMR INSERM U1060/INRA U1397, Université Claude Bernard Lyon1, F-69310 Pierre-Bénite et F-69500 Bron, France.ORCID 0000-0002-1587-2253
Håkan WesterbladDepartment of Physiology and Pharmacology, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID 0000-0002-8180-3029
David BendahanAix-Marseille Université, CRMBM UMR CNRS 7339, 13385 Marseille, France.ORCID 0000-0002-1502-0958
Charlotte GinesteAix-Marseille Université, CRMBM UMR CNRS 7339, 13385 Marseille, France.ORCID 0000-0001-8515-089X
Centre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial diseases are genetic disorders that lead to impaired mitochondrial function, resulting in exercise intolerance and muscle weakness. In patients, muscle fatigue due to defects in mitochondrial oxidative capacities commonly precedes muscle weakness. In mice, deletion of the fast-twitch skeletal muscle-specific Tfam gene (Tfam KO) leads to a deficit in respiratory chain activity, severe muscle weakness and early death. Here, we performed a time-course study of mitochondrial and muscular dysfunctions in 11- and 14-week-old Tfam KO mice, i.e. before and when mice are about to enter the terminal stage, respectively. Although force in the unfatigued state was reduced in Tfam KO mice compared to control littermates (wild type) only at 14 weeks, during repeated submaximal contractions fatigue was faster at both ages. During fatiguing stimulation, total phosphocreatine breakdown was larger in Tfam KO muscle than in wild-type muscle at both ages, whereas phosphocreatine consumption was faster only at 14 weeks. In conclusion, the Tfam KO mouse model represents a reliable model of lethal mitochondrial myopathy in which impaired mitochondrial energy production and premature fatigue occur before muscle weakness and early death.

Indexed as

Muscle FatigueMuscle WeaknessAnimalsDNA-Binding ProteinsHigh Mobility Group ProteinsHumansMiceMice, KnockoutMitochondriaMitochondrial ProteinsMuscle, SkeletalTranscription FactorsDNA-Binding ProteinsHigh Mobility Group ProteinsMitochondrial ProteinsTFAM protein, humanTfam protein, mouseTranscription FactorsEnergy metabolismExercise intoleranceMitochondrial myopathyMuscle fatigueMuscle weakness

Identifiers

PMID34378772
PMCPMC8461820
OpenAlexW3192631843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.